125 related articles for article (PubMed ID: 11156252)
1. Antisense of human peroxiredoxin II enhances radiation-induced cell death.
Park SH; Chung YM; Lee YS; Kim HJ; Kim JS; Chae HZ; Yoo YD
Clin Cancer Res; 2000 Dec; 6(12):4915-20. PubMed ID: 11156252
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death.
Yo YD; Chung YM; Park JK; Ahn CM; Kim SK; Kim HJ
Exp Mol Med; 2002 Sep; 34(4):273-7. PubMed ID: 12515392
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression.
Chen MF; Keng PC; Shau H; Wu CT; Hu YC; Liao SK; Chen WC
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):581-91. PubMed ID: 16414373
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxin IV protects cells from radiation-induced apoptosis in head-and-neck squamous cell carcinoma.
Park JJ; Chang HW; Jeong EJ; Roh JL; Choi SH; Jeon SY; Ko GH; Kim SY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1196-202. PubMed ID: 19251091
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of peroxiredoxin II confers resistance to cisplatin.
Chung YM; Yoo YD; Park JK; Kim YT; Kim HJ
Anticancer Res; 2001; 21(2A):1129-33. PubMed ID: 11396151
[TBL] [Abstract][Full Text] [Related]
6. Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines.
Bae JY; Ahn SJ; Han W; Noh DY
J Cell Biochem; 2007 Jul; 101(4):1038-45. PubMed ID: 17163455
[TBL] [Abstract][Full Text] [Related]
7. p53 status is a major determinant of effects of decreasing peroxiredoxin I expression on tumor growth and response of lung cancer cells to treatment.
Chen MF; Chen WC; Wu CT; Lin PY; Shau H; Liao SK; Yang CT; Lee KD
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1461-72. PubMed ID: 17084559
[TBL] [Abstract][Full Text] [Related]
8. Induction of radioprotective peroxiredoxin-I by ionizing irradiation.
Chen WC; McBride WH; Iwamoto KS; Barber CL; Wang CC; Oh YT; Liao YP; Hong JH; de Vellis J; Shau H
J Neurosci Res; 2002 Dec; 70(6):794-8. PubMed ID: 12444601
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated transfer of siRNA against peroxiredoxin I enhances the radiosensitivity of human intestinal cancer.
Zhang B; Wang Y; Liu K; Yang X; Song M; Wang Y; Bai Y
Biochem Pharmacol; 2008 Feb; 75(3):660-7. PubMed ID: 17976536
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma.
Kinnula VL; Lehtonen S; Sormunen R; Kaarteenaho-Wiik R; Kang SW; Rhee SG; Soini Y
J Pathol; 2002 Mar; 196(3):316-23. PubMed ID: 11857495
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M
Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789
[TBL] [Abstract][Full Text] [Related]
12. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.
Aloy MT; Hadchity E; Bionda C; Diaz-Latoud C; Claude L; Rousson R; Arrigo AP; Rodriguez-Lafrasse C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):543-53. PubMed ID: 17980509
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of peroxiredoxin in human breast cancer.
Noh DY; Ahn SJ; Lee RA; Kim SW; Park IA; Chae HZ
Anticancer Res; 2001; 21(3B):2085-90. PubMed ID: 11497302
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of two head and neck cancer cell lines presenting different radiation sensitivity.
Lee YS; Chang HW; Jeong JE; Lee SW; Kim SY
Acta Otolaryngol; 2008 Jan; 128(1):86-92. PubMed ID: 17917836
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxins in breast carcinoma.
Karihtala P; Mäntyniemi A; Kang SW; Kinnula VL; Soini Y
Clin Cancer Res; 2003 Aug; 9(9):3418-24. PubMed ID: 12960131
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of peroxiredoxin subtypes in human brain cell types.
Sarafian TA; Verity MA; Vinters HV; Shih CC; Shi L; Ji XD; Dong L; Shau H
J Neurosci Res; 1999 Apr; 56(2):206-12. PubMed ID: 10494109
[TBL] [Abstract][Full Text] [Related]
17. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
[TBL] [Abstract][Full Text] [Related]
18. Expression of 1-cys peroxiredoxin in the corneal wound-healing process.
Pak JH; Choi HJ; Choi CY; Tchah H
Cornea; 2006 Dec; 25(10 Suppl 1):S29-35. PubMed ID: 17001189
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 inhibitors potentiate the cytotoxic effects of radiation in Bcl-2 overexpressing radioresistant tumor cells.
Hara T; Omura-Minamisawa M; Chao C; Nakagami Y; Ito M; Inoue T
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):517-28. PubMed ID: 15667975
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin I and II are up-regulated during differentiation of epidermal keratinocytes.
Yun SJ; Seo JJ; Chae JY; Lee SC
Arch Dermatol Res; 2005 Jun; 296(12):555-9. PubMed ID: 15864612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
